Portail Guide

10. What are the specific features of wound healing in patients with burn injuries?

It is estimated that 400,000 people receive a burn injury in France each year (of which more than a third are children). Thus it is important that practitioners are able to accurately assess the wound. This assessment allows the patient to be referred to a specialised unit, if necessary, and be offered a suitable treatment to achieve optimal healing.


The depth of the burns corresponds to the anatomical level affected, and a distinction is made between:

superficial burns (1st degree and 2nd degree burns): medical treatment and healing without after-effects;

deep burns (2nd degree and 3rd degree): management generally requires the intervention of a plastic surgeon, and healing will involve after-effects (Figure7 and Table3).


Figure 7. Classification of burns in degrees.


Table 3. Differences in the clinicalvappearance of the burn depending on the degree.


In any burn injury, the wound should first be cooled down under running water for a prolonged time (about ten minutes). Pain management, which is often the primary concern, is essential. In common with all wounds, it is important to check the tetanus vaccination status of the patient.


Superficial burns should be treated by:

washing with soap and water;

excision of blisters (except on palmsof the hand and soles of the feet);

• daily tulle-gras dressing.


Healing normally occurs in under two weeks. If this is not the case, the patient should be referred to a specialist centre. Determining the depth of a burn is not always easy and the initial assessment may be incorrect and explain the delay in healing. For this reason, in second-degree burns, a reassessment after 24-48 hours is always required.


Deep burns should always be treated in a specialised burns centre for rapid flattening and grafting.





References


1. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341: 738-46.

2. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol2007; 127: 514-25.

3. Suivi en ville des plaies chroniques : ulcère veineux de jambe, escarre, plaie du pied diabétique. Assurance maladie, octobre 2015.

4. Plaies aiguës en structure d’urgence. Référentiel de bonnes pratiques. SFMU, 2017: 32 p.

5. Sgonc R, Gruber J. Age-related aspects of cutaneous wound hea- ling: a mini-review. Gerontology 2013; 59: 159-64.

6. Majtan J. Honey: an immunomodulator in wound healing. Wound Repair Regen 2014; 22: 187-92.

7. Opletalová K, BlaizotX, Mourgeon B, et al. Maggot therapyfor wound debridement: a randomized multicenter trial. Arch Dermatol 2012; 148: 432-8.

8. van den Broek LJ, Limandjaja GC, Niessen FB, Gibbs S. Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissueengineering perspective. ExpDer- matol 2014; 23: 382-6.

9. Prise en charge de l’ulcère de jambe à prédominance veineuse hors pansement. Recommandations HAS, 2006.

10. La compression médicale dans les affections veineuses chroniques. Fiche de bon usage HAS, 2010.

11. Edmonds M, Lázaro-Martínez JL, Alfayate-García JM, et al. Sucrose octasulfate dressing versus control dressing in patients with neu- roischaemic diabetic foot ulcers (Explorer): an international, multi- centre, double-blind, randomised, controlled trial [published correction appears in Lancet Diabetes Endocrinol 2018]. Lancet Diabetes Endocrinol 2018; 6: 186-96.

12. Reinholz M, Poetschke J, Schwaiger H, Epple A, Ruzicka T, Gauglitz GG. The dermatology life quality index as a means to assess life quality in patients with different scar types. J Eur Acad Dermatol Venereol 2015; 29: 2112-9.


<< 9. How to manage wound healing in cancer patients? >> 11. What dressing should be used according to the appearance of the wound?
© John Libbey Eurotext, 2021 This work may not be reproduced in whole or in part without the permission of the publisher or the Centre Francois d’Exploitation du Droit de Copie (CFC), 20, rue des Grands-Augustins, 75006 Paris, France.

With the institutional support of the laboratories